Madlen Jentzsch

Latest

• Single-Cell Multi-Omics of Peripheral Blood Reveals Tiding and Evolution of Responsive and Resistant Clones upon Daratumumab-Based Treatments in Multiple Myeloma and Plasma Cell Leukemia
• Prospective Phase II Study of Preemptive Chimerism-Driven Reduction of Immunosuppression after Non-Myeloablative Conditioning—Eudract #: 2007-002420-15